Literature DB >> 2571568

Physical mapping of human chromosome 17 using fragment-containing microcell hybrids.

R J Leach1, M J Thayer, A J Schafer, R E Fournier.   

Abstract

Hybrid cell lines were generated by microcell-mediated transfer of human chromosome 17 into rat recipient cells. The genotypes of 36 such lines were analyzed using a set of human chromosome 17-derived sequences to probe the structural integrity of the chromosome. Four classes of hybrids were obtained: clones with an apparently intact chromosome 17, clones containing large fragments of the chromosome including both the centromere and the selected marker, clones containing only the selected marker and flanking sequences, and clones containing two 17-derived fragments--the pericentric region plus the region of the selected marker. Data from these hybrids were used in conjunction with published regional localization information to obtain a provisional linear map of the chromosome. Results of this analysis are compared to the gene maps predicted from recent linkage studies and from other somatic cell hybrid experiments.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2571568     DOI: 10.1016/0888-7543(89)90043-8

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  14 in total

1.  Dissociation of cytotoxicity and DNA cleavage activity induced by topoisomerase II-reactive intercalating agents in hamster-human somatic cell hybrids.

Authors:  B S Glisson; A M Killary; P Merta; W E Ross; J Siciliano; M J Siciliano
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

Review 2.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M R Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 3.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 4.  Comparative map for mice and humans.

Authors:  J H Nadeau; M T Davisson; D P Doolittle; P Grant; A L Hillyard; M Kosowsky; T H Roderick
Journal:  Mamm Genome       Date:  1991       Impact factor: 2.957

5.  Variation in genomic Alu repeat density as a basis for rapid construction of low resolution physical maps of human chromosomes.

Authors:  M J Lane; P G Waterbury; W T Carroll; A M Smardon; B D Faldasz; S M Peshick; S Mante; C S Huckaby; R E Kouri; D J Hanlon
Journal:  Chromosoma       Date:  1992-03       Impact factor: 4.316

6.  The locus control region is necessary for gene expression in the human beta-globin locus but not the maintenance of an open chromatin structure in erythroid cells.

Authors:  A Reik; A Telling; G Zitnik; D Cimbora; E Epner; M Groudine
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

7.  A novel syndrome affecting multiple mitochondrial functions, located by microcell-mediated transfer to chromosome 2p14-2p13.

Authors:  A Seyda; R F Newbold; T J Hudson; A Verner; N MacKay; S Winter; A Feigenbaum; S Malaney; D Gonzalez-Halphen; A P Cuthbert; B H Robinson
Journal:  Am J Hum Genet       Date:  2001-01-10       Impact factor: 11.025

8.  Genetic mapping using microcell-mediated chromosome transfer suggests a locus for Nijmegen breakage syndrome at chromosome 8q21-24.

Authors:  S Matsuura; C Weemaes; D Smeets; H Takami; N Kondo; S Sakamoto; N Yano; A Nakamura; H Tauchi; S Endo; M Oshimura; K Komatsu
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

9.  Regulation of chimeric phosphoenolpyruvate carboxykinase genes by the trans-dominant locus TSE1.

Authors:  M J Thayer; T G Lugo; R J Leach; R E Fournier
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

10.  Definition of a tumor suppressor locus within human chromosome 3p21-p22.

Authors:  A M Killary; M E Wolf; T A Giambernardi; S L Naylor
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.